This report identifies germline heterozygous mutations in two patients, suggesting a potential role for MLH3 in endometrial carcinogenesis, which may act as a low-risk factor to increase the risk of tumor susceptibility and does not rule out the possibility of synergistic increases in pathogenicity with other genes. The gene discussed is MLH3; the disease is neoplasm.